Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | -35.85%2.73M | 115.38%4.25M | -9.08%1.98M | 2.34%2.17M | 52.63%2.12M | 1.39M |
| Revenue from customers | -41.71%2.06M | 79.06%3.54M | -9.08%1.98M | 2.34%2.17M | 52.63%2.12M | --1.39M |
| Other cash income from operating activities | -6.96%667.6K | --717.51K | ---- | ---- | ---2 | ---- |
| Cash paid | 11.52%-5.16M | -43.59%-5.83M | 12.15%-4.06M | -15.64%-4.62M | 26.07%-3.99M | -5.4M |
| Payments to suppliers for goods and services | 11.52%-5.16M | -43.59%-5.83M | 12.15%-4.06M | -15.64%-4.62M | 26.07%-3.99M | ---5.4M |
| Direct interest received | -73.57%8.3K | 54.16%31.4K | 435.46%20.37K | -21.03%3.8K | -57.49%4.82K | --11.33K |
| Direct tax refund paid | ---- | ---- | 25.35%669.63K | -36.11%534.21K | -21.23%836.1K | --1.06M |
| Operating cash flow | -56.95%-2.42M | -10.64%-1.54M | 27.05%-1.39M | -85.17%-1.91M | 64.94%-1.03M | ---2.94M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -24.86%-50.43K | 75.39%-40.39K | -718.30%-164.13K | 22.89%-20.06K | 14.14%-26.01K | -30.3K |
| Net PPE purchase and sale | -24.86%-50.43K | 75.39%-40.39K | -718.30%-164.13K | 22.89%-20.06K | 14.14%-26.01K | ---30.3K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -24.86%-50.43K | 75.39%-40.39K | -718.30%-164.13K | 22.89%-20.06K | 14.14%-26.01K | ---30.3K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 138.12%4.92M | 227.94%2.07M | -74.15%629.76K | 2,771.74%2.44M | -101.71%-91.18K | 5.33M |
| Net common stock issuance | 128.67%5.09M | 195.17%2.22M | -69.97%753.52K | --2.51M | ---- | --5.41M |
| Net other financing activities | 47.07%-168.27K | -28.43%-317.88K | -68.96%-247.52K | 19.67%-146.5K | -5.44%-182.36K | ---172.95K |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 138.12%4.92M | 227.94%2.07M | -74.15%629.76K | 2,771.74%2.44M | -101.71%-91.18K | --5.33M |
| Net cash flow | ||||||
| Beginning cash position | 48.66%1.48M | -50.67%994.15K | 15.89%2.02M | -34.18%1.74M | 692.46%2.64M | --333.36K |
| Current changes in cash | 405.69%2.45M | 152.27%484.39K | -282.56%-926.7K | 144.22%507.62K | -148.68%-1.15M | --2.36M |
| Effect of exchange rate changes | -4,829.19%-30.91K | 99.34%-627 | 59.22%-94.32K | -194.43%-231.3K | 595.85%244.96K | ---49.4K |
| End cash Position | 163.65%3.9M | 48.66%1.48M | -50.67%994.15K | 15.89%2.02M | -34.18%1.74M | --2.64M |
| Free cash from | -56.13%-2.47M | -1.57%-1.58M | 19.29%-1.56M | -80.49%-1.93M | 64.02%-1.07M | ---2.97M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |